Lack or loss of sexual desire. Hypoactive sexual desire disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Having sex with a partner for at least one year Having sexual dysfunction (FSD) for at least 6 months Patients' Satisfaction to participate in this study
Exclusion criteria
Exclusion criteria: Unwillingness of patients to continue to participate in the study History of allergic reactions to the drug Not taking the drug to treat vaginal atrophy in menopausal women No pregnancy and lactation Not recommended in patients with a history of low blood pressure, heart attack and pulmonary embolism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving sexual performance and satisfaction in women by measuring the increase of FSFI score. Timepoint: At the beginning of the study, the first week, the second week, the third week, the fourth week, the fifth week. Method of measurement: FSFI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improving the quality and satisfaction of sexual intercourse in women. Timepoint: The beginning of the study and the end of the study. Method of measurement: Female Sexual Function Index (FSFI) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences